v3.25.2
Intangible assets (Tables)
 12 Months Ended
Dec. 31, 2024
Notes and other explanatory information [abstract]  
Schedule of fair value of the asset
                       
   

Initial

Recognition

     Revaluation for the period     Fair Value  
    €     €     €  
BreastCheck IP Rights     60,000,000       0.00       60,000,000  
Tricos IP Rights     1,000,000       0.00       1,000,000  
Testic IP Rights     1,000,000       0.00       1,000,000  
Davion Masks IP Rights     1,500,000       0.00       1,500,000  
Bio-Genex IP Rights     1,000,000       0.00       1,000,000  
Merit IP Rights     500,000       0.00       500,000  
Total     65,000,000       0.00       65,000,000  
Schedule of intellectual property rights
     
   Intellectual Property Rights 
   € 
Cost     
      
Additions   65,000,000 
      
At December 31, 2023   65,000,000 
      
At December 31, 2024   65,000,000 
      
Carrying amount     
      
At December 31, 2024   65,000,000 
      
At December 31, 2023   65,000,000